DTIL Insider Transactions — Page 2
110 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–110; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| THOMSON DAVID S. | Chief Operating Officer | 2021-01-21 | Sale | 10,000.0 | $16.49 |
| Heery Christopher | Chief Medical Officer | 2019-12-19 | Purchase | 2,235.0 | $12.08 |
| Heery Christopher | Chief Medical Officer | 2019-12-19 | Purchase | 250.0 | $12.09 |
| YAO TONY DUNG LING | Director | 2019-04-03 | Purchase | 6,487.0 | $15.42 |
| FMR LLC | Other | 2019-04-01 | Purchase | 50,000.0 | $16.0 |
| GOODMAN COREY S | TenPercentOwner | 2019-04-01 | Purchase | 50,000.0 | $16.0 |
| Adelman Robert J | Director,TenPercentOwner | 2019-04-01 | Purchase | 50,000.0 | $16.0 |
| venBio Global Strategic Fund, L.P. | Director,TenPercentOwner | 2019-04-01 | Purchase | 50,000.0 | $16.0 |
| venBio Global Strategic GP, L.P. | TenPercentOwner | 2019-04-01 | Purchase | 50,000.0 | $16.0 |
| venBio Global Strategic GP, Ltd. | TenPercentOwner | 2019-04-01 | Purchase | 50,000.0 | $16.0 |